Competing stroke mechanisms despite adequate oral anticoagulant therapy: the role of transesophageal echocardiography.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
received:
03
06
2024
accepted:
13
09
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
aheadofprint
Résumé
Ischemic strokes in patients on oral anticoagulant therapy (OAT) despite optimal adherence pose a therapeutic challenge. We assessed the utility of transesophageal echocardiography (TEE) in identifying potential competing cardiac causes for stroke that occurred despite adequate OAT. This retrospective observational study included patients admitted for acute ischemic stroke between January 2022 and June 2023 who were on OAT for an established long-term indication. Transthoracic and transesophageal echocardiography, along with assessment of OAT adherence, were conducted. Demographic data, OAT details, and stroke characteristics were analysed to determine the influence of TEE findings on therapeutic decisions. We included 26 patients. TEE identified potential cardiac competing stroke mechanisms in 88% of cases, with valvular thrombi and left atrial or appendage thrombus being predominant. Infective endocarditis, often asymptomatic, was unexpectedly prevalent. TEE significantly influenced therapeutic decisions, especially in cases where transthoracic echocardiography was inconclusive. TEE may be crucial for unravelling the mechanisms of ischemic stroke in patients on adequate OAT, guiding precise therapeutic strategies and potentially reducing the risk of recurrent embolic events. Our findings underscore the limitations of standard echocardiography in detecting cardiac embolic sources and emphasize the importance of tailored decision-making in secondary stroke prevention.
Identifiants
pubmed: 39445527
doi: 10.2459/JCM.0000000000001673
pii: 01244665-990000000-00247
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45:3754–3832.
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke; 2021;52. Epub ahead of print July 2021. doi:10.1161/STR.0000000000000375.
Polymeris AA, Meinel TR, Oehler H, et al. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. J Neurol Neurosurg Psychiatry 2022; 93:588–598.
Seiffge DJ, De Marchis GM, Koga M, et al. Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Ann Neurol 2020; 87:677–687.
Gabet A, Chatignoux E, Grave C, et al. Stroke incidence and death in atrial fibrillation patients newly treated with direct oral anticoagulants. Clin Epidemiol 2021; 13:131–140.
Moira K, Kapral, Frank L. Silver, with the Canadian Task Force on Preventive Healthcare. Preventive healthcare, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. CMAJ 1999; 161:989.
Katsanos AH, Bhole R, Frogoudaki A, et al. The value of transesophageal echocardiography for embolic strokes of undetermined source. Neurology 2016; 87:988–995.
Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021; 23:1612–1676.
Flachskampf FA, Wouters PF, Edvardsen T, et al. Recommendations for transoesophageal echocardiography: EACVI update 2014. Eur Heart J Cardiovasc Imaging 2014; 15:353–365.
Sonaglioni A, Di Marco S, Pini P, et al. Misinterpretation of pedunculated myocardial trabeculae on transesophageal echocardiography: a case series. J Cardiovasc Med 2022; 23:755–756.
Sawczyńska K, Włodarczyk E, Pawlicka A, et al. Acute ischaemic stroke in patients treated with direct oral anticoagulants: potential causes, clinical characteristics, and short-term outcomes. Stroke Res Treat 2024; 2024:2285722.
Paciaroni M, Agnelli G, Caso V, et al. Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non–vitamin K antagonist oral anticoagulants for stroke prevention: the RENo Study. Stroke 2019; 50:2168–2174.
Raymond J, Imbert L, Cousin T, et al. Pharmacogenetics of direct oral anticoagulants: a systematic review. J Pers Med 2021; 11:37.
Marchetti G, Bernardini F, Romoli M, et al. Switching across direct oral anticoagulants: a real-life-setting pilot prospective study. J Cardiovasc Med (Hagerstown) 2021; 22:453–458.
Ip YMB, Lau KK, Ko H, et al. Association of alternative anticoagulation strategies and outcomes in patients with ischemic stroke while taking a direct oral anticoagulant. Neurology 2023; 101:e358–e369.
Duong E, Lin M, Hodgson M, et al. Choice of oral anticoagulant: outcomes in atrial fibrillation patients post-stroke despite direct oral anticoagulant use. CJC Open 2023; 5:603–610.
Hsieh M, Liu C, Lin S, et al. Comparing efficacy and safety between patients with atrial fibrillation taking direct oral anticoagulants or warfarin after direct oral anticoagulant failure. JAHA 2023; 12:e029979.
Lin S, Liao Y, Tang S, et al. Changing or retaining direct oral anticoagulant after ischemic stroke despite direct oral anticoagulant treatment. JAHA 2024; 13:e032454.
Curcio A, Anselmino M, Di Biase L, et al. The gray areas of oral anticoagulation for prevention of thromboembolic events in atrial fibrillation patients. J Cardiovasc Med (Hagerstown) 2023; 24:e97–e105.
Sciahbasi A, Gargiulo G, Talarico GP, et al. Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent. J Cardiovasc Med 2022; 23:738–743.
Côté G, Denault A. Transesophageal echocardiography-related complications. Can J Anesth 2008; 55:622–647.